Monoclonal gammopathy-associated pauci-immune extracapillary-proliferative glomerulonephritis successfully treated with bortezomib
Open Access
- 28 May 2013
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Kidney Journal
- Vol. 6 (3) , 327-329
Abstract
Extracapillary-proliferative glomerulonephritis is a rare complication of multiple myeloma. Partial remission of kidney involvement with cyclophosphamide therapy has previously been described. We report the case of a 60-year-old male patient diagnosed with rapidly progressive glomerulonephritis associated with IgG kappa monoclonal gammopathy. His kidney biopsy revealed pauci-immune extracapillary-proliferative glomerulonephritis without cryoglobulinaemia. Treatment with the proteasome inhibitor bortezomib induced rapid clinical and histological remission of his kidney disease. The patient's renal function remained stable on bortezomib maintenance therapy. Our findings suggest that bortezomib is a promising therapeutic approach to ameliorate severe kidney damage in monoclonal gammopathy- and myeloma-associated pauci-immune extracapillary-proliferative glomerulonephritis.Keywords
This publication has 18 references indexed in Scilit:
- Evolving Chemotherapy Options for the Treatment of Myeloma Kidney: A 40-Year PerspectiveAdvances in Chronic Kidney Disease, 2012
- Crescentic GlomerulonephritisAdvances in Anatomic Pathology, 2012
- Crescentic Glomerulonephritis in IgA Multiple Myeloma: A Case ReportNephron Extra, 2011
- Rituximab in induction therapy for anti-neutrophil cytoplasmic antibody (ANCA) vasculitisClinical and Experimental Immunology, 2011
- Myeloperoxidase-Specific Plasma Cell Depletion by Bortezomib Protects from Anti-Neutrophil Cytoplasmic Autoantibodies–Induced GlomerulonephritisJournal of the American Society of Nephrology, 2011
- Rituximab versus Cyclophosphamide for ANCA-Associated VasculitisNew England Journal of Medicine, 2010
- VMP (Bortezomib, Melphalan, and Prednisone) Is Active and Well Tolerated in Newly Diagnosed Patients With Multiple Myeloma With Moderately Impaired Renal Function, and Results in Reversal of Renal Impairment: Cohort Analysis of the Phase III VISTA StudyJournal of Clinical Oncology, 2009
- Rapidly progressive crescentic glomerulonephritisKidney International, 2003
- Small-Vessel VasculitisNew England Journal of Medicine, 1997
- Rapidly Progressive (‘Crescentic’) Glomerulonephritis and Monoclonal GammapathiesNephron, 1984